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mplantable Cardioverter-
efibrillator Shocks
Double-Edged Sword?*
erritt H. Raitt, MD, FACC
ortland, Oregon
n this issue of the Journal, Daubert et al. (1) report on
he details of inappropriate implantable cardioverter-
efibrillator (ICD) shocks in the MADIT II (Multi-
enter Automatic Defibrillator Trial II). The MADIT II
tudy (2) was a primary prevention ICD trial in which
atients with ischemic cardiomyopathy and an ejection
raction 0.30 were randomly assigned to ICD implanta-
ion or optimal medical therapy. Patients assigned to the
CD arm had significantly improved survival. The results of
ADIT II along with the results of the SCD-HeFT
Sudden Cardiac Death in Heart Failure Trial) (3) have led
o the recommendation that ICDs be implanted as primary
revention for sudden death in most patients with cardio-
yopathy and ejection fraction 0.30 to 0.40 (4). The
educed mortality seen in patients with ICDs compared
See page 1357
ith standard medical therapy is presumed to be on the
asis of ICD shocks terminating ventricular arrhythmias.
uring a mean follow-up of 20 months, 128 of 719 patients
ith ICDs in MADIT II had 393 appropriate shock
pisodes and 83 patients had 184 inappropriate shock
pisodes. The most common cause of inappropriate ICD
hocks was atrial fibrillation (AF), which accounted for 81
pisodes (44%), followed by other supraventricular tachy-
ardias, including sinus tachycardia leading to 67 episodes
36%), and abnormal sensing, which was the cause of 36
pisodes (20%). If appropriate ICD shocks save lives, it may
eem that a few inappropriate shocks is a small price to pay.
What is the down side of inappropriate shocks? There is
growing medical literature on the adverse psychological
onsequences of ICD shocks, whether appropriate or not.
he ICD shocks are perceived as very painful, and in one
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or thea
merican College of Cardiology.
From the Division of Cardiology, Portland VAMedical Center, Portland, Oregon.tudy were graded 4.0 on a 0 to 5 scale (5). After an ICD
hock, patients can be immobilized, fearing that any move-
ent or activity might trigger another shock. Multiple
hocks are the most frightening for patients, causing them
o wonder if the device is really working or if it might even
ill them (5–7). Those individuals who experience an ICD
hock relate greater levels of psychological distress, anxiety,
nger, and depression than those who do not (5–7). The
CD shocks lead to greater psychological distress for family
embers as well (7,8). Anxiety after ICD shocks remains
levated for an unknown amount of time, and then begins to
eturn to normal levels as long as no further shocks occur
9). Electrical storms, defined as having more than 3 shocks
n a 24-h period, occurs in 10% to 20% (10,11) of patients
uring the first 2 years after ICD implantation. Electrical
torm sets up an adverse conditioned response that includes
voidance of activities that may have been associated with
hocks, leading to heightened self-monitoring of bodily
unctions, increased anxiety, uncertainty, and increased
ependence. In some ICD patients this leads to a reactive
epression, helplessness, and post-traumatic stress disorder.
The MADIT II data raise the concern that inappro-
riate ICD shocks may not only have adverse psycholog-
cal consequences but may also have adverse medical
onsequences. Daubert et al. (1) observed that patients in
ADIT II who received inappropriate shocks had a higher
ortality than patients who did not, with a hazard ratio of
.29 (p  0.025). Similarly, patients with appropriate
hocks also had an increased overall mortality with a hazard
atio between 3 and 4, with the higher hazard in patients
ho had both appropriate and inappropriate shocks. Of
ourse this is only an association and in no way proves a
ausal link between ICD shocks and an increased risk of
eath. It is very reasonable to postulate that patients with
rogressive heart failure and therefore increased mortality
ight be more likely to develop AF and to have inappro-
riate ICD shocks. These same patients may also be more
ikely to have ventricular tachycardia or ventricular fibrilla-
ion develop as a result of progressive congestive heart
ailure and to have appropriate ICD shocks before dying of
ongestive heart failure. Similarly, patients not on beta-
locker therapy might be more likely to have ICD shocks
or sinus tachycardia, AF, or ventricular arrhythmias with
verall higher mortality related to the consequences of not
aking beta-blockers as apposed to being a result of ICD
hocks. However, close inspection of the MADIT II data
reates reason for concern. Depending on the ventricular
ate and ICD programming, AF and sinus tachycardia can
ead to antitachycardia pacing (ATP) instead of ICD
hocks. If rapid AF and sinus tachycardia are markers for
ncreased mortality, then one would expect inappropriate
TP to be associated with increased mortality as well. In
ontrast to this expectation, in the MADIT II population,
lthough both appropriate and inappropriate shocks were
ssociated with an increased total mortality, appropriate and
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April 8, 2008:1366–8 Editorial Commentnappropriate ATP were not. In fact, having only ATP
pisodes and no shocks was associated with a trend toward
ower mortality.
How could ICD shocks contribute to increased total
ortality? The primary concern is that ICD shocks might
amage the myocardium. An acute elevation of serum
roponin is a sensitive and specific marker of myocardial
amage. Although elevated troponin levels are not infre-
uently seen after ICD shocks, it is impossible to determine
hether the elevation is caused by myocardial ischemia and
njury related to the tachycardia that led to the shock or by
he shock itself. At the time of implantation, the ICD is
sually tested by inducing brief (10- to 15-s) episodes of
entricular fibrillation, which are then terminated by ICD
hocks. A few small studies have reported on troponin levels
efore and after uncomplicated ICD testing and report that
roponin elevation is not infrequently seen after testing,
uggesting the ICD shocks are capable of some level of
yocardial injury (12–14). This myocardial injury, although
ild, might be significant in patients who already have poor
entricular function and congestive heart failure. More
esearch needs to be done, including direct studies of left
entricular function and neurohumoral activity before and
fter ICD shocks, to give us better idea of what exactly the
dverse effects of ICD shocks might be.
It is also possible that there are adverse effects of ICD
hocks that could lead to increased mortality that are not the
esult of direct damage of the myocardium. I have already
utlined the adverse psychological effects of ICD shocks.
hese adverse effects include anxiety and depression. Both
nxiety and depression are known to be associated with a
orse prognosis in patients with congestive heart failure
15–17). Could the adverse psychological effects of ICD
hocks lead to anxiety and depression and a cascade of
vents that culminates in an increased risk of death in
atients with congestive heart failure?
Whether or not there is a causal relationship between
CD shocks and the associated increase in mortality, the
sychological effects of shocks alone are reason to do
verything possible to reduce the incidence of appropriate
nd inappropriate shocks. The ICD programming is the
rst line of defense. In the MADIT II trial AF was the most
ommon cause of inappropriate shocks, and patients who
ad the stability detection algorithm programmed on in
heir ICDs, which is designed to prevent shocks for AF,
ere less likely to have inappropriate shocks (1). There are
ther detection algorithms available on many ICDs that
valuate the morphology of tachycardias or the timing and
requency of atrial and ventricular activation to prevent
nappropriate shocks for supraventricular rhythms such as
F and sinus tachycardia. These algorithms help to prevent
nappropriate shocks.
The next step in reducing ICD shocks is programming to
se ATP instead of shocks whenever possible. Currently
any electrophysiologists do not routinely program ATP in
matients with ICDs. By protocol ATP was not turned on in
he SCD-HeFT (3). Arguing in favor of the utility and
fficacy of ATP is the Pain Free II study, which showed that
ggressive use of ATP even for very fast episodes of
entricular tachycardia was effective and reduced the risk of
hocks (18). Some physicians are worried that, if ineffective,
TP will delay tachycardia termination. In response, one
CD manufacturer has introduced a feature in which ATP
s used to try to terminate ventricular arrhythmias while the
apacitor is charging in preparation for an ICD shock. If the
TP works, the shock is aborted; if not, the shock is not
elayed. Given the adverse psychological effects of ICD
hocks and the possibility that shocks may increase mortal-
ty, these programming features should probably be used
henever possible. It is less clear whether medical therapy
an reduce the risk of ICD shocks. If, in fact, exacerbations
f congestive heart failure lead to ICD shocks, then perhaps
ore aggressive treatment of congestive heart failure in
atients with ICDs and use of congestive heart failure
onitoring protocols built into some ICDs might prevent
ome appropriate and inappropriate shocks. It is less clear
hether empiric antiarrhythmic therapy will prevent ICD
hocks, and such therapy cannot be recommended at this
ime because of the risk of proarrhythmia and the cardiac
nd noncardiac side effects of antiarrhythmic medications.
he final question is whether shocks related to ICD testing
ight have a detrimental effect on patients and whether
efibrillation testing should be done only in a limited subset
f patients or at all (19). Some have suggested given the
fficacy of modern ICDs that testing is not needed. Others
ave proposed alternative methods of testing ICD efficacy
hat require no or fewer ICD shocks. The potential benefits
f these strategies deserve further study.
The ICD shocks may well be a double-edged sword.
hey have been shown to prolog life as primary and
econdary prevention of sudden death in patients with
evere cardiomyopathy (3,4) and in patients with a history of
ife-threatening ventricular arrhythmias (20). However, the
hocks have important detrimental psychological effects,
nd the results of the analysis of inappropriate shocks in the
ADIT II study reported in this issue of the Journal (1)
how that inappropriate shocks are common and suggest
hat the same shocks that save lives by terminating ventric-
lar arrhythmias may paradoxically increase the risk of
eath. Additional research needs to be done to explore the
otential adverse effects of ICD shocks. In the meantime,
CD programming options currently available should be
sed to reduce the risk of inappropriate shocks, and ATP
hould be used instead of shocks whenever possible to
erminate ventricular arrhythmias.
eprint requests and correspondence: Dr. Merritt H. Raitt,
710 SW U.S. Veterans Road, Portland, Oregon 97239. E-mail:
erritt.raitt@va.gov.
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